Publish in this journal
Journal Information
Vol. 67. Issue 11.
Pages 964-965 (November 2014)
Vol. 67. Issue 11.
Pages 964-965 (November 2014)
Letter to the Editor
Full text access
Is Cocaine-associated Acute Myocardial Infarction the Same as Myocardial Infarction Associated With Recent Cocaine Consumption?
¿Los trastornos por cocaína asociados al infarto agudo de miocardio son lo mismo que el infarto de miocardio asociado al consumo reciente de cocaína?
Xavier Carrilloa,b,
Corresponding author
, Eduard Fernandez-Nofreriasa, Oriol Rodriguez-Leora,b, Antoni Bayes-Genisa,b
a Servicio de Cardiología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
b Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
Related content
Miguel Gili, Gloria Ramírez, Luis Béjar, Julio López, Dolores Franco, José Sala
Miguel Gili, Gloria Ramírez, Luis Béjar, Julio López
This item has received
Article information
Full Text
Download PDF
Full Text
To the Editor,

We read with great interest the article published recently by Gili et al,1 who studied the relationship between cocaine use disorder and the incidence and outcome of acute myocardial infarction by analyzing the Minimum Basic Data Set (MBDS) of 87 hospitals in Spain. The study concluded that cocaine use disorders increased the risk of myocardial infarction 3-fold, thereby extending hospital stay and increasing costs.

As the authors themselves note, the study design could be limited by MBDS coding, which may underestimate the prevalence of cocaine use. If we compare the data with a prospective registry run by our group of consecutive patients younger than 50 years, admitted with acute coronary syndrome, who underwent a structured interview on their history of chronic cocaine use and a cocaine metabolites urine test, the prevalence of cocaine use was 11.7% and recent use as demonstrated by the urine test results was 5.2%.2 These figures are much higher than those reported by Gili et al1 and are in line with other studies that systematically measured metabolites in urine.3 We should also remember that large biases may be present in the way patients with chest pain are questioned about cocaine use in clinical practice. In 44% of patients, the physician taking the medical history does not ask about cocaine, with obvious differences according to the individual's sociodemographic profile.4 Likewise, patients themselves are also a source of bias as a nonnegligible proportion do not admit to cocaine use even after a positive urine test result.2,3

In cases of acute myocardial infarction, recent cocaine use is an important prognostic factor in young patients, as it increases the complications of the acute myocardial infarction itself,5 as well as in-hospital mortality.2 In view of the importance of cocaine use as a prognostic factor and the difficulty of detecting such use in the initial contact, the European guideline on acute coronary syndrome recommends specific questions about cocaine use as part of the medical history and systematic measurement of cocaine metabolites in urine as part of the work-up.6

Assessment of the extent of cocaine use and myocardial infarction through the MBDS may be an interesting initial approach. However, we wonder whether the authors think that the prevalence of myocardial infarction associated with recent cocaine use may be underestimated, given the differences in the detection of cocaine use among studies. Could this underestimation and the greater age of patients with myocardial infarction at inclusion also have led to an underestimation of the prognostic effect of recent cocaine use on acute myocardial infarction? From our standpoint, we think it is important to differentiate between disorders arising from chronic cocaine use, which triples the risk of acute myocardial infarction, and acute cocaine use, which increases the complications and in-hospital mortality of infarction. We are therefore of the opinion that it is essential to specifically question patients with suspected myocardial infarction about chronic cocaine use and measure drug metabolites in urine.

M. Gili, G. Ramírez, L. Béjar, J. López, D. Franco, J. Sala.
Trastornos por cocaína e infarto agudo de miocardio, prolongación de estancias y exceso de costes hospitalarios.
Rev Esp Cardiol, 67 (2014), pp. 545-551
X. Carrillo, A. Curós, R. Muga, J. Serra, A. Sanvisens, A. Bayes-Genis.
Acute coronary syndrome and cocaine use: 8-year prevalence and in-hospital outcomes.
Eur Heart J, 32 (2011), pp. 1244-1250
X. Bosch, P. Loma-Osorio, E. Guasch, S. Nogue, J.T. Ortiz, M. Sanchez.
Prevalencia, características clínicas y riesgo de infarto de miocardio en pacientes con dolor torácico y consumo de cocaína.
Rev Esp Cardiol, 63 (2010), pp. 1028-1034
T.L. James, J. Feldman, S.D. Mehta.
Physician variability in history taking when evaluating patients presenting with chest pain in the emergency department.
Acad Emerg Med, 13 (2006), pp. 147-152
J.E. Hollander, R.S. Hoffman, J.L. Burstein, R.D. Shih, H.C. Thode Jr., Cocaine-Associated Myocardial Infarction Study Group.
Cocaine-associated myocardial infarction. Mortality and complications.
Arch Intern Med, 155 (1995), pp. 1081-1086
C.W. Hamm, J.-P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, et al.
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio.
Eur Heart J, 32 (2011), pp. 2999-3054
Copyright © 2014. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?